ArticleMaterials (Basel, Switzerland)2025
Multifunctional Organic Molecule for Defect Passivation of Perovskite for High-Performance Indoor Solar Cells.
Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Decoupling Intrinsic Molecular Efficacy From Platform Effects: An Interpretable Machine Learning Framework for Unbiased Perovskite Passivator Discovery.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Rational Design of Amino Acid-Modified Halide Perovskites for Highly Efficient and Cost-Effective Light-Emitting Diodes.Materials (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Perovskite solar cells (PSCs) can utilize the residual photons from indoor light and continuously supplement the energy supply for low-power electron devices, thereby showing the great potential for sustainable energy ecosystems. However, the solution-processed perovskites suffer from serious defect stacking within crystal lattices, compromising the low-light efficiency and operational stability. In this study, we designed a multifunctional organometallic salt named sodium sulfanilate (4-ABS), containing both electron-donating amine and sulfonic acid groups to effectively passivate the positively-charged defects, like under-coordinated Pb ions and iodine vacancies. The strong chemical coordination of 4-ABS with the octahedra framework can further regulate the crystallization kinetics of perovskite, facilitating the enlarged crystal sizes with mitigated grain boundaries within films. The synergistic optimization effects on trap suppression and crystallization modulation upon 4-ABS addition can reduce energy loss and mitigate ionic migration under low-light conditions. As a result, the optimized device demonstrated an improved power conversion efficiency from 22.48% to 24.34% and achieved an impressive efficiency of 41.11% under 1000 lux weak light conditions. This research provides an effective defect modulation strategy for synergistically boosting the device efficiency under standard and weak light irradiations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.